🚀 Proud to have contributed to @LITMUS_IMI ! Our study highlights the potential of non-invasive biomarkers for earlier MASLD diagnosis and fewer liver biopsies. authors.elsevier.com/c/1o11c… #MASLD #MASH @livertweet @Unicatt
🌍 Proud to contribute to the IMPROVEMENT study on liver transplant outcomes across 61 centres worldwide.
authors.elsevier.com/sd/arti…
Thanks to @VatcheAgopianMD and @Alfonso_AVOLIO for including me!
#IMPROVEMENT #LiverTransplantation @livertweet
Luca Miele retweeted
🔵 Novità per la salute del fegato nei #LEA2026!
✅ Elastografia epatica
✅ HDV-RNA quantitativo
✅ Esenzioni per malattie autoimmuni
✅ Appropriatezza dell'AFP
Un passo avanti per diagnosi e presa in carico, anche grazie all'impegno di #AISF e delle realtà coinvolte @Epatite
🤖 Made with AI
Luca Miele retweeted
#Savethedate | 27 maggio, ore 9:30
In diretta streaming l’evento istituzionale dedicato al 60° anniversario del primo trapianto eseguito con successo in Italia, alla presenza del Ministro della Salute Orazio Schillaci.
🔗 Segui la diretta: youtube.com/watch?v=-HheqZwF…
Luca Miele retweeted
Il Prof. Antonio Gasbarrini, Dir. Scientifico Fondazione Policlinico Universitario Agostino Gemelli IRCCS spiega l'importanza degli screening per le epatiti virali, i rischi a cui si può andare incontro e gli strumenti terapeutici di cui si dispone.
youtu.be/-iu9JM2qLjc
Luca Miele retweeted
📢 Upcoming #EASLDeepDive on 25 June, 18:00 CEST
How should we diagnose and stratify risk in #MASLD?
Join experts as they explore the 2024 EASL–EASD–EASO Guidelines:
👉New MASLD definition & SLD framework
👉Non-invasive tests: when, how, for whom
👉#HCC risk & surveillance beyond cirrhosis
Register here: easl-eu.zoom.us/webinar/regi…
#LiverX
Luca Miele retweeted
📍 19 aprile #WorldLiverDay!
🏙️ Tutti hanno un ruolo nel favorire l'accesso al cibo salutare, fondamentale per salvaguardare la prevenzione delle malattie del fegato sin dall'età infantile 👦👧
#ilciboèmedicina @WorldLiverDay
Luca Miele retweeted
🔴 19 aprile #WorldLiverDay!
Anche quest'anno AISF è in prima linea nelle celebrazioni della Giornata Mondiale del Fegato e per ricordare l'importanza della prevenzione.
Lo suggerisce anche lo slogan del @WorldLiverDay 2025 #ilciboèmedicina.
🚨 We're hiring! 🚨
Join the #DARE - Digital Lifelong Prevention project at Gemelli Hospital, Rome as a Scientific Project Manager. Work on MASLD research in a top-tier, multidisciplinary team.
📩 Apply now 👉 linkedin.com/jobs/search/?cu…
#Hiring #MASLD #Research #Healthcare
Luca Miele retweeted
Si è aperto oggi a Roma il 4° "AISF Training Day" della Scuola di Epatologia AISF, dal titolo "Bedside Approach and Precision Medicine In Liver Diseases", un'occasione di formazione e crescita professionale per specializzandi e giovani specialisti.
Luca Miele retweeted
New #GUTOnline paper by Porcari et al on
"Prevalence of irritable bowel syndrome and functional dyspepsia after acute gastroenteritis: systematic review and meta-analysis" via
bit.ly/46hBDo6
@DrCJBlack @GiovanniCammar9 @gianluca1aniro @alex_ford12399 #IBS
Luca Miele retweeted
At @EASLnews we’re excited to welcome Prof. @VladRatziu as the incoming Editor-in-Chief of the EASL 🌟 flagship Journal @JHepatology
The EASL Governing Board looks forward to his leadership of the journal over the next 5 years.
📢EASL proudly announces the appointment of Prof. @VladRatziu as the new Editor-in-Chief of the @JHepatology: the premier publication in the field of liver research.
"With the ultimate aim to serve academic research, we will strive to select, improve upon and disseminate the most inspiring and innovative advances in all fields of hepatobiliary diseases. While promoting cutting-edge research, we will work in synergy with EASL to enrich our educational mission for clinicians and scientists, and keep the Journal’s pages open to contributors from all parts of the world who wish to engage in a healthy and vibrant scientific debate." - Prof. Ratziu
👏We extend our heartfelt congratulations to Prof. Ratziu and look forward to the continued success and growth of the journal.
easl.eu/news/new-eic-journal…
Luca Miele retweeted
🟪NEW Article in press❕
Waiting list mortality and 5-year transplant survival benefit of patients with #MASLD: an Italian liver transplant registry study.
🔓#OpenAccess at 👉jhep-reports.eu/article/S258…
#LiverTwitter
Luca Miele retweeted
🆕REVIEW❕
Immunotherapy for hepatocellular carcinoma
➡️The next evolution in expanding access to liver transplantation
Full text here👉journal-of-hepatology.eu/art…
#LiverTwitter
Luca Miele retweeted
Interventional radiology meets immuno-oncology for hepatocellular carcinoma
By Riad Salem & @TimGreten
Full review here👉bit.ly/3VqlfN1
#LiverTwitter
Luca Miele retweeted
Liver transplantation for MASLD
Higher waiting list mortality, same post transplant survival, and, thus, higher transplant benefit…. higher priority also?
sciencedirect.com/science/ar…
Luca Miele retweeted
The @LITMUS_IMI Histopathology Group 🔬🧬scored >1️⃣0️⃣0️⃣0️⃣ samples and devised the 🥇Human Histology Proximity Score for approximation of murine #MASLD histology to human! Multidisciplinary work at its best 💪🏻💪🏻! @ESP_Pathology @uoaofficial @UniofNewcastle @EASLnews @UKLiverPath – at Melissia, Greece
Which preclinical model best recapitulates #MASLD metabolic/fibrosing aspects? Does an ideal model exist? The @LITMUS_IMI Preclinical Group screened the phenotype, histopathology and transcriptome of common murine MASLD models benchmarked against humans
nature.com/articles/s42255-0…
Luca Miele retweeted
Another state of the art lecture from @docberza about the non-invasive measurement of CSPH
👉🏼 This is more cost effective than endoscopy
👉🏼 40-60% of patients are in the grey zone
👉🏼 Adding spleen stiffness is very helpful
#EASLCongress
Luca Miele retweeted
The "Love Your Liver" project at the opening ceremony of the annual EASL meeting. This initiative, in collaboration with AISF and the Universities of Padua, Palermo, Cattolica of Sacro Cuore in Rome, and Humanitas University of Milan aims to promote liver health and awareness

































